1 / 20

E-Prescribing Market Size, Share, Demand, Report, Forecast 2024-2032

The global e-prescribing market size reached US$ 2.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.3 Million by 2032, exhibiting a growth rate (CAGR) of 21.05% during 2024-2032.

Emily150
Download Presentation

E-Prescribing Market Size, Share, Demand, Report, Forecast 2024-2032

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global E-Prescribing Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

  2. About IMARC Group • International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. • IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. • IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. Report Highlight and Description • According to the latest report by IMARC Group, titled "E-Prescribing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"The global e-prescribing market size reached US$ 2.2 Million in 2023. • The global e-prescribing market is experiencing substantial growth, driven by the increasing adoption of healthcare IT solutions aimed at improving patient care and streamlining healthcare processes. Government initiatives and regulatory mandates promoting the use of e-prescribing to enhance medication safety and reduce prescription errors are further propelling market growth. Along with this, the rising prevalence of chronic diseases, necessitating frequent medication management, is also boosting the demand for efficient e-prescribing systems. Technological advancements, such as the integration of e-prescribing with electronic health records (EHRs) and the implementation of cloud-based solutions, are enhancing the functionality and accessibility of e-prescribing platforms. Additionally, the growing focus on reducing healthcare costs and improving operational efficiencies in healthcare facilities is encouraging the adoption of e-prescribing. Moreover, the increasing awareness among healthcare providers about the benefits of e-prescribing, including enhanced prescription accuracy and patient safety, is also contributing to the market expansion. • Looking forward, IMARC Group expects the market to reach US$ 12.3 Million by 2032, exhibiting a growth rate (CAGR) of 21.05% during 2024-2032. • Request for a PDF sample of this report: • https://www.imarcgroup.com/e-prescribing-market/requestsample

  4. Report Description • Global E-Prescribing Market Trends: • The market encompasses a broad range of applications, including medication management, patient monitoring, and clinical decision support, reflecting its critical role in modern healthcare. Market growth analysis indicates a robust upward trajectory, supported by continuous technological innovations and the increasing integration of advanced features such as predictive analytics and AI-driven insights. The market is also benefiting from the expanding adoption of telemedicine, which leverages e-prescribing to provide seamless and efficient remote healthcare services. The rising demand for mobile health applications and the increasing penetration of smartphones and internet connectivity are facilitating the widespread use of e-prescribing systems. • Strategic collaborations between healthcare providers, technology vendors, and pharmaceutical companies are fostering the development of comprehensive e-prescribing solutions tailored to meet specific clinical needs. Furthermore, the growing focus on personalized medicine and the implementation of value-based care models are expected to drive sustained growth in the global e-prescribing market, solidifying its position as a key component of the digital healthcare ecosystem. • View Report TOC, Figures and Tables: https://www.imarcgroup.com/e-prescribing-market

  5. Breakup by Component: • Solutions • Services • Breakup by Delivery Mode: • Web-Based • Cloud-Based • On-Premises • Breakup by End User: • Hospitals • Pharmacies • Office-Based Physicians • Others Report Segmentation

  6. Breakup by Specialties: • Oncology • Sports Medicine • Neurology • Cardiology • Others • Breakup by Region: • North America (United States, Canada) • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) • Latin America (Brazil, Mexico, Others) • Middle East and Africa Report Segmentation

  7. Competitive Landscape • Allscripts Healthcare Solutions Inc. • Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital) • Cerner Corporation • Computer Programs and Systems Inc. • DrFirst.com Inc. • Epic Systems Corporation • Henry Schein Inc. • Medical Information Technology Inc. • Nextgen Healthcare Inc. • Surescripts LLC

  8. Key Questions Answered in the Report What is the expected growth rate of the global e-prescribing market during 2024-2032? What are the key factors driving the global e-prescribing market? What has been the impact of COVID-19 on the global e-prescribing market? What is the breakup of the global e-prescribing market based on the component? What is the breakup of the global e-prescribing market based on the delivery mode? What is the breakup of the global e-prescribing market based on end user?

  9. Key Questions Answered in the Report What is the breakup of the global e-prescribing market based on the specialties? What are the key regions in the global e-prescribing market? Who are the key players/companies in the global e-prescribing market?

  10. 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global E-Prescribing Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Component 6.1 Solutions 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Services 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Delivery Mode 7.1 Web-Based 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Cloud-Based Table of Contents

  11. 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 On-Premises 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Pharmacies 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Office-Based Physicians 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Specialties 9.1 Oncology 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Sports Medicine 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Neurology 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Cardiology 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others Table of Contents

  12. 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast Table of Contents

  13. 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast Table of Contents

  14. 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Allscripts Healthcare Solutions Inc. 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital) 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio Table of Contents

  15. 15.3.3 Cerner Corporation 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.3.3 Financials 15.3.3.4 SWOT Analysis 15.3.4 Computer Programs and Systems Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 DrFirst.com Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.6 Epic Systems Corporation 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 SWOT Analysis 15.3.7 Henry Schein Inc. 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 Medical Information Technology Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.9 Nextgen Healthcare Inc. 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.9.4 SWOT Analysis 15.3.10 Surescripts LLC 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio Table of Contents

  16. Table of Contents For more information, visit: https://www.imarcgroup.com/e-prescribing-market/toc

  17. Partial List of Clients

  18. Partial List of Clients

  19. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

  20. Contact Us Visit us at : https://www.imarcgroup.com • +1-631-791-1145 • sales@imarcgroup.com Stay With Us:

More Related